These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1790032)

  • 1. Patterns of physicians' treatments for referral patients from public cholesterol screening.
    Maiman LA; Greenland P; Hildreth NG; Cox C
    Am J Prev Med; 1991; 7(5):273-9. PubMed ID: 1790032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dental screening and referral of young children by pediatric primary care providers.
    dela Cruz GG; Rozier RG; Slade G
    Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of public cholesterol screening on diet, general well-being, and physician referral.
    Hyman DJ; Flora JA; Reynolds KD; Johannsson MB; Farquhar JW
    Am J Prev Med; 1991; 7(5):268-72. PubMed ID: 1790031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public cholesterol screening in the previously diagnosed: misuse of resources or beneficial function?
    Maiman LA; Greenland P; Hildreth NG; Cox C
    Am J Prev Med; 1994; 10(1):20-5. PubMed ID: 8172727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of screening and referral on follow-up and treatment of high blood cholesterol levels.
    Råstam L; Luepker RV; Pirie PL
    Am J Prev Med; 1988; 4(5):244-8. PubMed ID: 3224000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the efficacy of the National Cholesterol Education Program adult treatment guidelines: cholesterol lowering intervention program.
    Caggiula AW; Watson JE; Milas NC; Olson MB; Kuller LH; Orchard TJ
    Prev Med; 1995 Sep; 24(5):485-91. PubMed ID: 8524723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use and outcomes of a cholesterol-lowering intervention for rural elderly subjects.
    Ives DG; Kuller LH; Traven ND
    Am J Prev Med; 1993; 9(5):274-81. PubMed ID: 8257616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for high blood cholesterol.
    Schucker B; Bradford RH
    Clin Lab Med; 1989 Mar; 9(1):29-36. PubMed ID: 2647374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ['Cholesterol' guideline (first revision) of the Dutch College of Family Physicians; response from the family practice].
    van den Bosch WJ
    Ned Tijdschr Geneeskd; 2000 Feb; 144(9):404-7. PubMed ID: 10719541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population screening and referral for hypercholesterolemia.
    Råstam L; Luepker RV; Mittelmark MB; Murray DM; Slater JS; Blackburn H
    Am J Prev Med; 1988; 4(5):249-54. PubMed ID: 3224001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician reaction to a local community cholesterol screening program.
    Buchta WG; Wissell RA; Bagley RC; Greaves WW
    Arch Intern Med; 1989 Nov; 149(11):2479-81. PubMed ID: 2818108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community screening for hypercholesterolemia.
    Bell MM; Joseph S
    J Fam Pract; 1990 Oct; 31(4):365-8. PubMed ID: 2212966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attendance patterns and characteristics of participants in public cholesterol screening.
    Greenland P; Hildreth NG; Maiman LA
    Am J Prev Med; 1992; 8(3):159-64. PubMed ID: 1633003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of community pharmacists' experiences with cholesterol screening programs.
    Jungnickel PW; Wisehart DA
    J Am Pharm Assoc (Wash); 1997; NS37(6):640-6. PubMed ID: 9425793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment and counseling of coronary risk factors by family practice residents.
    Neighbor WE; Scott CS; Schaad DC; Macdonald SC; Van Citters R
    J Fam Pract; 1991 Mar; 32(3):273-81. PubMed ID: 2002318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in cholesterol awareness and action. Results from national physician and public surveys.
    Schucker B; Wittes JT; Santanello NC; Weber SJ; McGoldrick D; Donato K; Levy A; Rifkind BM
    Arch Intern Med; 1991 Apr; 151(4):666-73. PubMed ID: 2012446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family physicians' perspectives on ovarian cancer.
    Gray RE; Chart P; Carroll JC; Fitch MI; Cloutier-Fisher D
    Cancer Prev Control; 1999 Feb; 3(1):61-7. PubMed ID: 10474754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of reimbursement criteria on the appropriateness of 'statin' prescribing.
    Autier P; Creplet J; Vansant G; Brohet C; Paquot N; Muls E; Mullie P; Grivegnée AR
    Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):456-62. PubMed ID: 14671469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.